MedPath

A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease

Phase 2
Completed
Conditions
Fibrocystic Disease of Breast
Interventions
Drug: Placebo
Registration Number
NCT00744276
Lead Sponsor
FemmePharma Global Healthcare, Inc.
Brief Summary

The purpose of this study is to determine the safety of three doses of topically applied danazol compared to placebo in subjects with pain associated with fibrocystic breast disease and to determine the appropriate clinical dose for future studies.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Menstruating females at least 18 years of age
  • Has moderate to severe breast pain associated with cyclical fibrocystic breast disease
  • Is in good general health
Exclusion Criteria
  • Pregnant within the past 6 months or lactating
  • History of malignancy or currently being treated for cancer of the breast or genital organs
  • Has taken within the past 3 months or is currently taking hormonal contraception
  • Has any condition for which an androgen or steroid is contraindicated
  • Has had breast implants or breast reduction surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
6Placebo-
5Placebo-
4Placebo-
1danazol-
2danazol-
3danazol-
Primary Outcome Measures
NameTimeMethod
Subject reported breast pain as measured using a visual analog scale on the subject daily diary2 cycles pretreatment plus 4 cycles on treatment
Secondary Outcome Measures
NameTimeMethod
Physician assessment of breast nodularity at each treatment cycle visit2 cycles pretreatment plus 4 cycles on treatment

Trial Locations

Locations (29)

Women's Health Research

🇺🇸

Phoenix, Arizona, United States

Advanced Clinical Therapeutics, LLC

🇺🇸

Tucson, Arizona, United States

Impact Clinical Trials

🇺🇸

Las Vegas, Nevada, United States

Women's Health Care at Frost Street

🇺🇸

San Diego, California, United States

Horizons Clinical Research Center, LLC

🇺🇸

Denver, Colorado, United States

James A Simon, M.D., PC

🇺🇸

Washington, District of Columbia, United States

Visions Clinical Research

🇺🇸

Boynton Beach, Florida, United States

Southeastern Integrated Medical, LLC

🇺🇸

Gainsville, Florida, United States

Palm Beach Research Center

🇺🇸

West Palm Beach, Florida, United States

Atlanta North Gynecology, PC

🇺🇸

Roswell, Georgia, United States

Scroll for more (19 remaining)
Women's Health Research
🇺🇸Phoenix, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.